2019
DOI: 10.1107/s2052252519013137
|View full text |Cite
|
Sign up to set email alerts
|

Toward G protein-coupled receptor structure-based drug design using X-ray lasers

Abstract: A method is presented for efficient co-crystal structure determination for G protein-coupled receptors taking advantage of serial femtosecond crystallography.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
47
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 64 publications
(55 citation statements)
references
References 84 publications
2
47
0
Order By: Relevance
“…During the last five years, about a dozen novel GPCR structures have been determined benefiting from XFEL data collection . In the case of MT receptors, using the CXI beamline at the Linac Coherent Light Source (LCLS) we were able to obtain structures of MT 1 and MT 2 bound to different agonists at resolutions between 2.8 and 3.3 Å (Table )—we attribute the remarkable gain in resolution for MT 1 at XFEL sources to the specific packing of the receptor in alternating layers with strong and weak contacts (Fig. ), as cryo‐cooling causes contraction of the crystal lattice, introducing defects in the lattice hence limiting resolution.…”
Section: Structure Determination Of Mt Receptorsmentioning
confidence: 97%
“…During the last five years, about a dozen novel GPCR structures have been determined benefiting from XFEL data collection . In the case of MT receptors, using the CXI beamline at the Linac Coherent Light Source (LCLS) we were able to obtain structures of MT 1 and MT 2 bound to different agonists at resolutions between 2.8 and 3.3 Å (Table )—we attribute the remarkable gain in resolution for MT 1 at XFEL sources to the specific packing of the receptor in alternating layers with strong and weak contacts (Fig. ), as cryo‐cooling causes contraction of the crystal lattice, introducing defects in the lattice hence limiting resolution.…”
Section: Structure Determination Of Mt Receptorsmentioning
confidence: 97%
“…The combination of high flux and sub-micron focus beam (<1 µm × 1 µm) allows microcrystals (<5 µm 3 ) of angiotensin II receptor [53], δ-opioid receptor [54], CPV17 polyhedrin [55] and melatonin receptor 2 (MT2) [56] to be used for data collection, which otherwise did not provide sufficient diffraction volume at synchrotron. Serial crystallography thus represents the next frontier in X-ray crystallography and has the potential to address the crystallization bottleneck of requiring large, well-diffracting crystals of membrane proteins for SBDD [57][58][59]. A further unique potential of XFEL is the femtosecond data collection regime, allowing time-resolved dynamic studies at sub-picosecond timescales relevant to many biological processes.…”
Section: Xfel and Serial Crystallographymentioning
confidence: 99%
“…Ligand soaking into crystals in LCP has been demonstrated [216], proving that LCP retains the water channel structure which allows the efficient diffusion of small molecules and opens up the possibility of soaking experiments for samples prepared for the LCP jet. To increase throughput and collect multiple ligand complex datasets for β2 adrenergic receptor at LCLS and SACLA, protein was purified in the presence of either timolol or alprenolol and replaced with another ligand of equal or higher affinity during crystallization in LCP [59]. SFX data were then collected for each receptor/ligand complex per loading run, with data collection times between 0.5 to 3 h, depending on hit rate, XFEL repetition rate, indexing rate and the degree of data convergence (typically >10,000 indexed images) required for the purpose of the experiment [59].…”
Section: Sample Delivery Present and Futurementioning
confidence: 99%
See 1 more Smart Citation
“…Extracting crystals from the viscous LCP is difficult, and many membrane protein crystals only grow to a few micrometers in their largest dimension. Even when relatively large crystals are available, soaking drugs into them is not always feasible, limiting SBDD applications for GPCRs (14). Therefore, structural investigations of GPCRs were greatly facilitated by the advent of X-ray free electron lasers (XFEL) with injector-based LCP delivery systems (10,15,16).…”
Section: Main Textmentioning
confidence: 99%